Stavanger University Hospital Inflammatory Bowel Disease Trial (SUSI)

Helse Stavanger HF

Status: Enrolling

Conditions: IBD

Study type: Observational

Funder types: Other

Identifiers

NCT01551563

SUSI_1

Details and patient eligibility

About

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.

Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

Full description

none considered needed

Enrollment: 700 estimated patients

Sex: All

Ages: 16 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• newly diagnosed IBD

Exclusion criteria

• previous IBD with specific treatment within 10 year
• inability to consent
• inability to adhere to treatment protocol